Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry study.

Nuri KaradurmusMuhammet Ali KaplanMehmet Ali Nahit SendurYuksel UrunUmut DemirciSaziye Burcak KaracaSabin Göktas AydinMusa Baris AykanAhmet BiliciAhmet SezerUlku YilmazHuseyin AbaliPerran Fulden YumukSerkan DegirmenciogluAhmet DemirkazikSemra PaydasCem MiriliHande TurnaAysegul KargiMustafa OzdoganDeniz Can GuvenMustafa OzgurogluSaadettin Kilickap

Published in: Current medical research and opinion (2024)

Nivolumab is safe and effective in the 2L or 3L/LL treatment of locally advanced/metastatic NSCLC and associated with acceptable AEs in real-life setting.

Keyphrases

locally advanced
squamous cell carcinoma
small cell lung cancer
rectal cancer
neoadjuvant chemotherapy
radiation therapy
phase ii study
brain metastases
placebo controlled